MedPath

Laboratorios Osorio de Moraes Ltda.

Ownership
Private
Established
1944-01-01
Employees
-
Market Cap
-
Website

Study to Assess the Efficacy and Safety of "Pílulas de Lussen®" Compared to the Pyridium® in the Symptomatic Control of Dysuria

Phase 3
Conditions
Dysuria
Interventions
First Posted Date
2009-09-01
Last Posted Date
2009-09-01
Lead Sponsor
Laboratorios Osorio de Moraes Ltda.
Target Recruit Count
80
Registration Number
NCT00969254

Phase III Open Study, Prospective, Multicenter, Randomized, Comparative to the Positive Control for Evaluating the Efficacy and Safety of Auris-Sedina in the Symptomatic Control of Otalgy in Patients With or Without Acute External Otitis.

Phase 3
Conditions
Otitis
Efficacy
Tolerability
Interventions
Drug: Otosynalar®
First Posted Date
2009-08-27
Last Posted Date
2009-08-27
Lead Sponsor
Laboratorios Osorio de Moraes Ltda.
Target Recruit Count
188
Registration Number
NCT00967317
Locations
🇧🇷

Faculdade de Medicina do ABC, Santo André, São Paulo, Brazil

© Copyright 2025. All Rights Reserved by MedPath